A functional, multispecific CD8+ T-cell response correlates with HBV control during acute hepatitis (26), maintains the inactive carrier state during persistent HBV infection (3), and appears necessary to achieve functional cure after treatment withdrawal of nucleos(t)ide analogues (6, 27). This evidence concerns the gene CD8A and Acute hepatitis.